Pancreatic Cancer Research

ResearcherUniversity of ChicagoNo recent work listed

Blasé N. Polite

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8743-8096; OpenAlex author ID A5064525249. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper, 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. Co-author DOI 10.1002/jso.24872↗
  2. A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcino… Co-author DOI 10.1186/2051-1426-1-8↗

Trials 1

  1. Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials Principal investigator NCT02020252↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel V.T. Catenacci · 2 shared papers, 2013–2018 · strength 0.11
  2. Hedy Lee Kindler · 2 shared papers, 2013–2018 · strength 0.11
  3. Marshall S. Baker · 1 shared paper, 2018 · strength 0.07
  4. Marina Talamonti · 1 shared paper, 2018 · strength 0.07
  5. Kevin King Roggin · 1 shared paper, 2018 · strength 0.07
  6. Jeffrey B. Matthews · 1 shared paper, 2018 · strength 0.07
  7. Robert Marsh · 1 shared paper, 2018 · strength 0.07
  8. Mitchell C. Posner · 1 shared paper, 2018 · strength 0.07
  9. Daniel M. Geynisman · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.